You have 9 free searches left this month | for more free features.

Oxaliplatin

Showing 2526 - 2550 of 2,879

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rectal Carcinoma Trial in Japan (S-1, Oxaliplatin, Radiation)

Unknown status
  • Rectal Carcinoma
  • Nagoya, Japan
  • +5 more
Nov 26, 2012

Colorectal Cancer Trial in Canada, United States (FOLFOX regimen, fluorouracil, leucovorin calcium)

Completed
  • Colorectal Cancer
  • FOLFOX regimen
  • +3 more
  • Scottsdale, Arizona
  • +23 more
Feb 4, 2013

Gastric Adenocarcinoma Trial in Avignon (Docetaxel - Cisplatine - 5FU, Radiation of 45 Grays on 5 weeks)

Unknown status
  • Gastric Adenocarcinoma
  • Docetaxel - Cisplatine - 5FU
  • Radiation of 45 Grays on 5 weeks
  • Avignon, France
    Institut Sainte Catherine
Dec 20, 2012

Colorectal Tumor Trial in Anyang (OS (oxalipaltin+S-1), XELOX (oxalipaltin+capecitabine))

Completed
  • Colorectal Neoplasm
  • OS (oxalipaltin+S-1)
  • XELOX (oxalipaltin+capecitabine)
  • Anyang, Korea, Republic of
    Hallym University Medical Center
Oct 4, 2012

Colorectal Cancer, Metastatic Cancer Trial in United Kingdom (biological, drug, other, procedure)

Unknown status
  • Colorectal Cancer
  • Metastatic Cancer
  • cetuximab
  • +8 more
  • Basildon, England, United Kingdom
  • +21 more
Jan 22, 2013

Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment) Trial in

Completed
  • Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment)
  • Barcelona, Spain
  • +9 more
Nov 8, 2012

Adenocarcinoma of the Gastroesophageal Junction Trial in Lublin (preoperative chemo- and chemoradiotherapy, Surgical resection)

Unknown status
  • Adenocarcinoma of the Gastroesophageal Junction
  • preoperative chemo- and chemoradiotherapy
  • Surgical resection
  • Lublin, Lubelskie, Poland
    Second Department of General & Gastrointestinal Surgery & Oncolo
Feb 2, 2013

Advanced Colorectal Cancer, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Worldwide (ABT-869, bevacizumab,

Completed
  • Advanced Colorectal Cancer
  • +2 more
  • Chapel Hill, North Carolina
  • +45 more
May 7, 2013

Pancreatic Cancer Trial in Munich (drug, procedure, radiation)

Completed
  • Pancreatic Cancer
  • gemcitabine hydrochloride
  • +5 more
  • Munich, Germany
    Klinikum Rechts Der Isar - Technische Universitaet Muenchen
Dec 11, 2012

Colorectal Cancer Trial in Greece (Irinotecan, Capecitabine, Cetuximab)

Terminated
  • Colorectal Cancer
  • Heraklion, Creta, Greece
  • +9 more
Feb 12, 2013

Colorectal Tumors Trial in United States (bevacizumab, AG-013726, AG-013736 (axitinib))

Completed
  • Colorectal Neoplasms
  • Daphne, Alabama
  • +106 more
Nov 7, 2013

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in San Antonio (drug, biological, other)

Terminated
  • Adenocarcinoma of the Colon
  • +7 more
  • oxaliplatin
  • +5 more
  • San Antonio, Texas
    Southwest Oncology Group
Jan 24, 2013

Rectal Cancer Trial in Ottawa (IXO regimen)

Unknown status
  • Rectal Cancer
  • IXO regimen
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Oct 12, 2012

Advanced Pancreatic Cancer Trial in Sutton (Gemcitabine, Oxaliplatin, Imatinib)

Completed
  • Advanced Pancreatic Cancer
  • Sutton, Surrey, United Kingdom
    Royal Marsden NHS Foundation Trust
Sep 21, 2012

Gastric Cancer Trial in St Louis, Chapel Hill, Nashville (drug, genetic, other)

Completed
  • Gastric Cancer
  • St Louis, Missouri
  • +4 more
Oct 30, 2012

Stomach Tumors Trial in Anyang, Seoul (DOS (Docetaxel, Oxaliplatin and S-1))

Completed
  • Stomach Neoplasms
  • DOS (Docetaxel, Oxaliplatin and S-1)
  • Anyang, Korea, Republic of
  • +1 more
Sep 20, 2012

Colonic Tumors Trial in Guangzhou (cytokine-induced killer cells)

Unknown status
  • Colonic Neoplasms
  • cytokine-induced killer cells
  • Guangzhou, Guangdong, China
    Guangdong Provincial Hospital of Chinese Medicine
Aug 27, 2013

Colorectal Cancer Trial in United States (trastuzumab, fluorouracil, leucovorin calcium)

Terminated
  • Colorectal Cancer
  • trastuzumab
  • +3 more
  • Birmingham, Alabama
  • +46 more
May 1, 2013

Colorectal Cancer Trial in Delft, Den Haag, Leiden (biological, drug, other)

Unknown status
  • Colorectal Cancer
  • panitumumab
  • +2 more
  • Delft, Netherlands
  • +3 more
Sep 16, 2013

Colorectal Cancer, Metastatic Cancer Trial in United States (biological, drug, procedure)

Withdrawn
  • Colorectal Cancer
  • Metastatic Cancer
  • bevacizumab
  • +3 more
  • Los Angeles, California
  • +45 more
Jan 2, 2013

To Compare the Monitoring of Circulating Tumor DNA With the Efficacy of Chemo Evaluated by Computer Tomography Scan. Trial in

Unknown status
  • To Compare the Monitoring of Circulating Tumor DNA With the Efficacy of Chemotherapy Evaluated by Computer Tomography Scan.
    • Paris, France
    • +1 more
    Nov 5, 2013

    Gastric Cancer, Adenocarcinoma of the Esophagogastric Junction Trial in Frankfurt (Docetaxel, 5-Fluorouracil, Oxaliplatin)

    Completed
    • Gastric Cancer
    • Adenocarcinoma of the Esophagogastric Junction
    • Frankfurt, Germany
      Krankenhaus Nordwest
    Sep 18, 2012

    Cholangiocarcinoma Trial in Munich (Gemcitabine, Oxaliplatin, Photodynamic therapy (Photosan®))

    Withdrawn
    • Cholangiocarcinoma
    • Gemcitabine, Oxaliplatin, Photodynamic therapy (Photosan®)
    • Munich, Germany
      Technical University of Munich at the Klinikum rechts der Isar I
    Aug 9, 2012

    Ovarian Cancer Trial in Bridgewater (Bevacizumab (Avastin®), Docetaxel (Taxotere®), Oxaliplatin (Eloxatin®))

    Completed
    • Ovarian Cancer
    • Bevacizumab (Avastin®)
    • +2 more
    • Bridgewater, New Jersey
      Sanofi-Aventis Administrative Office
    Jul 20, 2012

    Cholestasis, Progressive Familial Intrahepatic 3 Trial in Paris (Yttrium microsphere injection)

    Terminated
    • Cholestasis, Progressive Familial Intrahepatic 3
    • Yttrium microsphere injection
    • Paris, France
      Hôpital Saint Antoine. Service d'Hépatologie, Pole digestif.
    Aug 6, 2013